Literature DB >> 22067323

Mutual regulation of growth hormone and bone morphogenetic protein system in steroidogenesis by rat granulosa cells.

Eri Nakamura1, Fumio Otsuka, Kenichi Inagaki, Tomoko Miyoshi, Yoshinori Matsumoto, Kanako Ogura, Naoko Tsukamoto, Masaya Takeda, Hirofumi Makino.   

Abstract

GH induces preantral follicle growth and differentiation with oocyte maturation. However, the effects of GH on ovarian steroidogenesis and the mechanisms underlying its effects have yet to be elucidated. In this study, we investigated the actions of GH on steroidogenesis by rat granulosa cells isolated from early antral follicles by focusing on the ovarian bone morphogenetic protein (BMP) system. We found that GH suppressed FSH-induced estradiol production with reduction in aromatase expression and, in contrast, GH increased FSH-induced progesterone level with induction of steroidogenic acute regulatory protein, side chain cleavage cytochrome P450, and 3β-hydroxysteroid dehydrogenase. The effects of GH on steroidogenesis by granulosa cells were enhanced in the presence of the BMP antagonist noggin. Coculture of GH with oocytes did not alter GH regulation of steroidogenesis. Steroid production induced by cAMP donors was not affected by GH treatment and the GH effects on FSH-induced steroid production were not accompanied by changes in cAMP synthesis, suggesting that GH actions were not directly mediated by the cAMP-protein kinase A pathway. GH exerted synergistic effects on MAPK activation elicited by FSH, which regulated FSH-induced steroidogenesis. In addition, GH-induced signal transducer and activator of transcription phosphorylation was involved in the induction of IGF-I expression. GH increased IGF-I, IGF-I receptor, and FSH receptor expression in granulosa cells, and inhibition of IGF-I signaling restored GH stimulation of FSH-induced progesterone production, suggesting that endogenous IGF-I is functionally involved in GH effects on progesterone induction. BMP inhibited IGF-I effects that increased FSH-induced estradiol production with suppression of expression of the GH/IGF-I system, whereas GH/IGF-I actions impaired BMP-Sma and Mad related protein 1/5/8 signaling through down-regulation of the expression of BMP receptors. Thus, GH acts to modulate estrogen and progesterone production differentially through endogenous IGF-I activity in granulosa cells, in which GH-IGF-I interaction leads to antagonization of BMP actions including suppression of FSH-induced progesterone production. Mutual balance between GH/IGF-I and BMP signal intensities may be a key for regulating gonadotropin-induced steroidogenesis in growing follicles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067323     DOI: 10.1210/en.2011-1646

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions.

Authors:  Kerry L Hull; Steve Harvey
Journal:  Int J Endocrinol       Date:  2014-12-15       Impact factor: 3.257

2.  Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein.

Authors:  Kosuke Kimura; Tomohiro Terasaka; Nahoko Iwata; Takayuki Katsuyama; Motoshi Komatsubara; Ryota Nagao; Kenichi Inagaki; Fumio Otsuka
Journal:  J Clin Med       Date:  2017-01-05       Impact factor: 4.241

Review 3.  Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?

Authors:  Jesús Devesa; Cristina Almengló; Pablo Devesa
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2016-10-12

4.  Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial.

Authors:  Jingyu Li; Qiaoli Chen; Jiang Wang; Guoning Huang; Hong Ye
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-20       Impact factor: 3.007

Review 5.  Modulation of bone morphogenetic protein activity by melatonin in ovarian steroidogenesis.

Authors:  Fumio Otsuka
Journal:  Reprod Med Biol       Date:  2018-02-26

Review 6.  Growth Hormone and Insulin-Like Growth Factor Action in Reproductive Tissues.

Authors:  Emina Ipsa; Vinicius F Cruzat; Jackob N Kagize; John L Yovich; Kevin N Keane
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-12       Impact factor: 5.555

7.  Effects of growth hormone co-treatment on in vitro fertilization outcomes in women with expected normal ovarian response

Authors:  Fırat Tülek; Alper Kahraman
Journal:  Turk J Obstet Gynecol       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.